Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 30;6(5):349-356.
doi: 10.1016/j.ijwd.2020.07.015. eCollection 2020 Dec.

Dermatologic toxicities associated with radiation therapy in women with breast cancer

Julie Y Ramseier  1 , Michelle N Ferreira  1 , Jonathan S Leventhal  1
Affiliations
Review

Dermatologic toxicities associated with radiation therapy in women with breast cancer

Julie Y Ramseier et al. Int J Womens Dermatol. .

Abstract

Breast-conserving surgery with adjuvant radiation therapy has become the standard of care for women with early stage breast cancer, and as a result, a large number of patients are affected by the cutaneous sequelae of radiation therapy. These dermatologic toxicities may present during treatment or years later and can significantly impact patients' quality of life. In this review, we discuss the clinical presentation, prevention, and management of radiation-induced cutaneous toxicities in women with breast cancer, including radiation dermatitis, radiation recall, radiation-induced morphea, radiation-induced fibrosis, and cutaneous malignancies in irradiated skin.

Keywords: Breast cancer; Cutaneous toxicities; Oncodermatology; Radiation dermatitis; Radiation therapy; Radiation-induced morphea.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Acute radiation dermatitis manifesting as erythematous patches with dry desquamation weeks after radiation therapy for breast cancer. (B) Severe presentation of acute radiation dermatitis manifesting as moist desquamation.
Fig. 2
Fig. 2
Radiation-induced morphea presenting as a round erythematous plaque with a violaceous border on the lateral breast.
Fig. 3
Fig. 3
Radiation-induced fibrosis presenting as marked contracture and breast deformity. Note the surrounding chronic radiation changes, including dyspigmentation and telangiectasias.
Fig. 4
Fig. 4
(A) Atypical vascular lesion presenting as a red papule on an irradiated chest. (B) Radiation-induced telangiectasias localized to the radiation field.
See this image and copyright information in PMC

References

    1. Bahaj W., Ya’qoub L., Toor M., Masood A. Radiation recall in a patient with intrahepatic cholangiocarcinoma: case report and a literature review. Cureus. 2019;11(6):e5020. - PMC - PubMed
    1. Barnes J., Mayes M.D. Epidemiology of systemic sclerosis: Incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol. 2012;24(2):165–170. - PubMed
    1. Ben-David M.A., Elkayam R., Gelernter I., Pfeffer R.M. Melatonin for prevention of breast radiation dermatitis: a phase II, prospective, double-blind randomized trial. Isr Med Assoc J. 2016;18(3–4):188–192. - PubMed
    1. Billings S.D., McKenney J.K., Folpe A.L., Hardacre M.C., Weiss S.W. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28(6):781–788. - PubMed
    1. Bleasel N.R., Stapleton K.M., Commens C., Ahern V.A. Radiation-induced localized scleroderma in breast cancer patients. Australas J Dermatol. 1999;40(2):99–102. - PubMed